• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD Back to Search Results
Model Number 4473
Medical Device Problem Codes Signal Artifact/Noise (1036); Failure to Capture (1081); Fracture (1260); High impedance (1291); Under-Sensing (1661); High Capture Threshold (3266)
Health Effect - Clinical Code Bradycardia (1751)
Date of Event 08/20/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that this right atrial (ra) lead exhibited high out of range pacing impedances measuring above 2500 ohms, with undersensing, high pacing thresholds, noise, and suspected loss of capture with an atrial rhythm of 30 beats per minute caused by a lead fracture.Technical services (ts) was consulted, and programming options were advised.The physician opted to perform the programming enhancements.No additional adverse patient effects were reported.This lead remains in service.
 
Additional Manufacturer Narrative
This product remains implanted and has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.Review of labeling determined the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance with labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.A risk review was completed and confirmed that the event of fracture was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
It was reported that this right atrial (ra) lead exhibited high out of range pacing impedances measuring above 2500 ohms, with undersensing, high pacing thresholds, noise, and suspected loss of capture with an atrial rhythm of 30 beats per minute caused by a lead fracture.Technical services (ts) was consulted, and programming options were advised.The physician opted to perform the programming enhancements.No additional adverse patient effects were reported.This lead remains in service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II EZ STEROX
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23026321
Report Number2124215-2025-63884
Device Sequence Number18596845
Product Code DTB
UDI-Device Identifier00802526265020
UDI-Public(01)00802526265020(17)040125
Combination Product (Y/N)Y
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P960004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2002
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/25/2004
Device Model Number4473
Device Catalogue Number4473
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/20/2025
Supplement Date Received by Manufacturer04/15/2026
Initial Report FDA Received Date09/11/2025
Supplement Report FDA Received Date04/17/2026
Date Device Manufactured01/25/2002
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age88 YR
Patient SexMale
-
-